Dicerna to Participate in Citi’s 2018 Global Healthcare Conference

07:30 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive offic...

Other Sources for this Article

Investor Contact:
Rx Communications Group
Paula Schwartz, 917-322-2216

Media Contact:
Alex Van Rees, 973-442-1555 ext. 111


More From BioPortfolio on "Dicerna to Participate in Citi’s 2018 Global Healthcare Conference"

Quick Search

Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...